Clobex is owned by Galderma Labs.
Clobex contains Clobetasol Propionate.
Clobex has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Clobex are:
Clobex was authorised for market use on 05 February, 2004.
Clobex is available in shampoo;topical dosage forms.
Clobex can be used as topical treatment of scalp psoriasis.
The generics of Clobex are possible to be released after 03 January, 2022.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US7700081||GALDERMA LABS||Foaming compositions for hair care|| |
(1 year, 2 months ago)
Drugs and Companies using CLOBETASOL PROPIONATE ingredient
Market Authorisation Date: 05 February, 2004
Treatment: Topical treatment of scalp psoriasis
Korea, Republic of
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic